Needham & Company
-
Needham Reiterates Buy Rating on Axon Enterprise (AXON)
-
Axon Enterprise (AXON) PT Raised to $870 at Needham
-
Axon Enterprise (AXON) PT Raised to $820 at Needham
-
Axon to Release First Quarter 2025 Earnings on May 7, 2025
-
Needham Reiterates Buy Rating on Axon Enterprise (AXON)
-
Needham Reiterates Buy Rating on Axon Enterprise (AXON)
-
Axon Enterprise (AXON) PT Raised to $600 at Needham
-
Axon to Release Third Quarter 2024 Earnings on November 7, 2024
-
Axon Enterprise (AXON) PT Raised to $525 at Needham
-
Axon Enterprise (AXON) PT Raised to $400 at Needham
-
Axon to Release Third Quarter 2023 Earnings on November 7, 2023
-
Needham & Company's new conviction list stock offers nearly 40% upside
-
Axon to Release First Quarter 2023 Earnings on May 9, 2023
-
Axon Enterprise (AXON) PT Raised to $240 at Needham & Company on TASER 10 Release
-
Axon to Release Third Quarter 2022 Earnings on November 8, 2022
-
Needham & Company Assumes Axon Enterprise (AXON) at Buy
-
Axon Enterprise (AXON) PT Lowered to $130 at Needham & Company
-
Axon to Release First Quarter 2022 Earnings on May 10, 2022
-
Axon Enterprise (AXON) PT Lowered to $170 at Needham & Company
-
3 Reasons Why Axon Enterprise (AXON) Shares Are Up 20% Today
-
Axon to Release Third Quarter 2021 Earnings on November 9, 2021
-
Axon to Release Second Quarter 2021 Earnings on August 5, 2021
-
Axon Enterprise (AXON) Invests $90M in Israel's Cellebrite, Which is Going Public via a SPAC
-
Axovant Sciences (AXON) PT Raised to $190 at Needham & Company

